Ultrasound as an outcome measure to assess disease activity in disorders of skin thickening: An example of the use of radiologic techniques to assess skin disease

Dermatologic Therapy

Volumn 20, Issue 2, 2007, Pages 86-92

  Bendeck, Sandra E ^a,b   Jacobe, Heidi T ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Morphea; Outcome measure; Scleroderma; Ultrasound

Indexed keywords

CALCIPOTRIOL; COLECALCIFEROL; CORTICOSTEROID; METHOTREXATE; PSORALEN; STEROID;

ACCURACY; CLINICAL PRACTICE; CLINICAL TRIAL; CORRELATION ANALYSIS; DISEASE ACTIVITY; HUMAN; MEASUREMENT; MORPHEA; OUTCOME ASSESSMENT; PHOTOTHERAPY; QUANTITATIVE ANALYSIS; RADIOLOGY; REVIEW; SCLERODERMA; SKIN DISEASE; SKINFOLD; TECHNOLOGY; ULTRASOUND;

HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); SCLERODERMA, LOCALIZED; TREATMENT OUTCOME;

EID: 34249299114     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2007.00116.x     Document Type: Review

References (47)

1. Schmid-Wendtner MH, Burgdorf W. Ultrasound scanning in dermatology. Arch Dermatol 2005 : 141 : 217 224.
2. Slone R, Huda W. Review of radiologic physics. In : Ultrasound. Media, PA : Williams & Wilkins, 1995 : 151 170.
3. Williamson MR. Physics in ultrasound. In : Essentials of ultrasound. Philadelphia, PA : W.B. Saunders Company, 1996 : 1 28.
4. Bushong SC. Diagnostic ultrasound. New York : McGraw-Hill, 2006.
5. Bushberg JT, Selbert JA, Leidholdt EM Jr., Boone JM. Ultrasound. In : PasQno WM III., ed. The essentials of medical imaging, 2nd ed. Philadelphia, PA : Lippincott, Williams & Wilkins, 2002 : 367 416.
6. Pope JE, Bellamy N. Outcome measurement in scleroderma clinical trials. Semin Arthritis Rheum 1993 : 23 : 22 33.
7. White B, Bauer EA, Goldsmith LA, et al. Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis. Arthritis Rheum 1995 : 38 : 351 360.
8. Seibold JR, McCloskey DA. Skin involvement as a relevant outcome measure in clinical trials of systemic sclerosis. Curr Opin Rheumatol 1997 : 9 : 571 575.
9. Bolognia JL, Jorizzo JL, Rapini RR, et al. Systemic sclerosis (scleroderma). In : Dermatology 2003 : 625 632.
10. Roecken M, Ghoreschi K. Morphea and lichen sclerosus. In : Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. Edinburgh : Elsevier, 2003 : 1503 1517.
11. Dykes PJ, Francis AJ, Marks R. Measurement of dermal thickness with the Harpenden skinfold caliper. Arch Dermatol Res - Arch Fur Dermatologische Forsch 1976 : 256 : 261 263.
12. Clements PJ, Lachenbruch PA, Seibold JR, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in three independent studies. J Rheumatol 1920 : (11 1892.
13. Pope JE, Baron M, Bellamy N, et al. Variability of skin scores and clinical measurements in scleroderma. J Rheumatol 1995 : 22 : 1271 1276.
14. Clements P, Lachenbruch P, Siebold J, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995 : 22 : 1281 1285.
15. Seibold JR, Furst DE, Clements PJ. Why everything (or nothing) seems to work in the treatment of scleroderma. J Rheumatol 1919 : (5 673.
16. McKee PH, Calonje E, Granter SR. Localized scleroderma. In : Houston M, ed. Pathology of the skin with clinical correlations, 3rd ed. Philadelphia, PA : Elsevier, 2005 : 815 821.
17. McKee PH, Calonje E, Granter SR. Systemic sclerosis. In : Houston M, ed. Pathology of the skin with clinical correlations, 3rd ed. Philadelphia, PA : Elsevier, 2005 : 804 815.
18. Brennan P, Silman A, Black C, et al. Reliability of skin involvement measures in scleroderma. The UK Scleroderma Study Group. Br J Rheumatol 1992 : 31 : 457 460.
19. Black CM. Measurement of skin involvement in scleroderma. J Rheumatol 1995 : 22 : 1217 1219.
20. Seyger MM, vanden Hoogen FH, de BT, et al. Reliability of two methods to assess morphea: skin scoring and the use of a durometer. J Am Acad Dermatol 1997 : 37 : 793 796.
21. Aghassi D, Monoson T, Braverman I. Reproducible measurements to quantify cutaneous involvement in scleroderma. Arch Dermatol 1995 : 131 : 1160 1166.
22. Seyger MM, vanden Hoogen FH, de BT, et al. Low-dose methotrexate in the treatment of widespread morphea. J Am Acad Dermatol 1998 : 39 : 220 225.
23. Falanga V, Bucalo B. Use of a durometer to assess skin hardness. J Am Acad Dermatol 1993 : 29 : 47 51.
24. Dobrev HP. In vivo study of skin mechanical properties in patients with systemic sclerosis. J Am Acad Dermatol 1999 : 40 : 436 442.
25. Enomoto DN, Mekkes JR, Bossuyt PM, et al. Quantification of cutaneous sclerosis with a skin elasticity meter in patients with generalized scleroderma. J Am Acad Dermatol 1996 : 35 (3 Pt 1 381 387.
26. Alexander H, Miller DL. Determining skin thickness with pulsed ultrasound. J Invest Dermatol 1979 : 72 : 17 19.
27. Tan CY, Statham B, Marks R, et al. Skin thickness measurement by pulsed ultrasound: its reproducibility, validation and variability. Br J Dermatol 1982 : 106 : 657 667.
28. Serup J. Localized scleroderma (morphoea): thickness of sclerotic plaques as measured by 15 MHz pulsed ultrasound. Acta Derm Venereol 1984 : 64 : 214 219.
29. Serup J. Quantification of acrosclerosis: measurement of skin thickness and skin-phalanx distance in females with 15 MHz pulsed ultrasound. Acta Derm Venereol 1984 : 64 : 35 40.
30. Akesson A, Forsberg L, Hederstrom E, et al. Ultrasound examination of skin thickness in patients with progressive systemic sclerosis (scleroderma). Acta Radiol Diagn 1986 : 27 : 91 94.
31. Cosnes A, Anglade MC, Revuz J, et al. Thirteen-megahertz ultrasound probe: its role in diagnosing localized scleroderma. Br J Dermatol 2003 : 148 : 724 729.
32. Hoffmann K, Gerbaulet U, el-Gammal S, et al. 20-MHz B-mode ultrasound in monitoring the course of localized scleroderma (morphea). Acta Derm Venereol 1991 : 164 (Suppl 3 16.
33. Myers SL, Cohen JS, Sheets PW, et al. B-mode ultrasound evaluation of skin thickness in progressive systemic sclerosis. J Rheumatol 1986 : 13 : 577 580.
34. Moore TL, Lunt M, McManus B, et al. Seventeen-point dermal ultrasound scoring system - a reliable measure of skin thickness in patients with systemic sclerosis. Rheumatol 2003 : 42 : 1559 1563.
35. Scheja A, Akesson A. Comparison of high-frequency (20 MHz) ultrasound and palpation for the assessment of skin involvement in systemic sclerosis (scleroderma). Clin Exp Rheumatol 1997 : 15 : 283 288.
36. Brocks K, Stender I, Karlsmark T, et al. Ultrasonic measurement of skin thickness in patients with systemic sclerosis. Acta Derm Venereol 2000 : 80 : 59 60.
37. Hashikabe M, Ohtsuka T, Yamazaki S. Quantitative echographic analysis of photochemotherapy on systemic sclerosis skin. Arch Dermatol Res 2005 : 296 : 522 527.
38. Kreuter A, Gambichler T, Breukmann F, et al. Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma. [erratum appears in Arch Dermatol. 2005 Sep; 141(9):1091]. Arch Dermatol 2005 : 141 : 847 852.
39. Kreuter A, Breukmann F, Uhle A, et al. Low-dose UVA1 phototherapy in systemic sclerosis: effects on acrosclerosis. J Am Acad Dermatol 2004 : 50 : 740 747.
40. Kreuter A, Gambichler T, Avermaete A, et al. Combined treatment with calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea. Pediatr Dermatol 2001 : 18 : 241 245.
41. Kerscher M, Volkenundt M, Gruss C, et al. Low-dose UVA phototherapy for treatment of localized scleroderma. J Am Acad Dermatol 1998 : 38 : 21 26.
42. Kerscher M, Meurer M, Sander C, et al. PUVA bath photochemotherapy for localized scleroderma. Evaluation of 17 consecutive patients. Arch Dermatol 1996 : 132 : 1280 1282.
43. Kerscher M, Dirschka T, Volkenandt M. Treatment of localised scleroderma by UVA1 phototherapy. Lancet 1995 : 346 : 1166.
44. Stege H, Berneburg M, Humke S, et al. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol 1997 : 36 : 938 944.
45. Cammarota T, Pinto F, Magliaro A, et al. Current uses of diagnostic high-frequency US in dermatology. Eur J Radiol 1998 : 27 (Suppl. 2 S215 S223.
46. Akesson A, Hesselstrand R, Scheja A, et al. Longitudinal development of skin involvement and reliability of high frequency ultrasound in systemic sclerosis. Ann Rheum Dis 2004 : 63 : 791 796.
47. Serup J. Decreased skin thickness of pigmented spots appearing in localized scleroderma (morphoea). Measurement of skin thickness by 15 MHz pulsed ultrasound. Arch Dermatol Res 1984 : 276 : 135 137.